A Study to Evaluate Safety, Tolerability and Immune Response in Adolescents Allergic to Peanut After Receiving Intradermal Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein DNA Plasmid Vaccine
Clinical trial NCT03755713 · COMPLETED
Trial details
- NCT number
- NCT03755713
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-12
- Primary completion
- 2021-10-11
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.